Curtana Pharmaceuticals' Angel Round

Curtana Pharmaceuticals raised a round of funding on February 15, 2017.

Curtana Pharmaceuticals is developing small molecule therapies for the treatment of brain cancer, including glioblastoma in adults and pediatric high-grade glioma in children.…

Articles about Curtana Pharmaceuticals' Angel Round: